These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

407 related items for PubMed ID: 16926600

  • 21. Foxp3+ T cells in peripheral blood of renal transplant recipients and clinical correlations.
    Lin WX, Christiansen D, Fu LL, Roberts MA, Sandrin MS, Ierino FL.
    Nephrology (Carlton); 2012 May; 17(4):415-22. PubMed ID: 22308996
    [Abstract] [Full Text] [Related]

  • 22. Sirolimus vs mycophenolate moftile in Tacrolimus based therapy following induction with Antithymocyte globulin promotes regulatory T cell expansion and inhibits RORγt and T-bet expression in kidney transplantation.
    Jamali S, Sarafnejad A, Ahmadpoor P, Nafar M, Karimi M, Eteghadi A, Yekaninejad MS, Amirzargar AA.
    Hum Immunol; 2019 Sep; 80(9):739-747. PubMed ID: 30597187
    [Abstract] [Full Text] [Related]

  • 23. Late conversion from calcineurin inhibitor-based to sirolimus-based immunosuppression due to chronic toxicity: a prospective study with protocol biopsy amendment.
    Uslu A, Töz H, Sen S, Alkan FT, Nart A, Aykas A, Doğan M, Postaci H, Sahin T, Simşek C.
    Transplant Proc; 2009 Mar; 41(2):756-63. PubMed ID: 19328973
    [Abstract] [Full Text] [Related]

  • 24. Conversion from a calcineurin inhibitor to everolimus therapy in maintenance liver transplant recipients: a prospective, randomized, multicenter trial.
    De Simone P, Metselaar HJ, Fischer L, Dumortier J, Boudjema K, Hardwigsen J, Rostaing L, De Carlis L, Saliba F, Nevens F.
    Liver Transpl; 2009 Oct; 15(10):1262-9. PubMed ID: 19790150
    [Abstract] [Full Text] [Related]

  • 25. Intrarenal vascular resistance parameters in kidney transplant patients receiving calcineurin inhibitor-based or sirolimus-based regimens.
    Lee PC, Lee CY, Hu RH, Lo C, Tsai MK, Lee PH.
    Nephrol Dial Transplant; 2010 May; 25(5):1675-80. PubMed ID: 20042398
    [Abstract] [Full Text] [Related]

  • 26. A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function.
    Watson CJ, Gimson AE, Alexander GJ, Allison ME, Gibbs P, Smith JC, Palmer CR, Bradley JA.
    Liver Transpl; 2007 Dec; 13(12):1694-702. PubMed ID: 18044728
    [Abstract] [Full Text] [Related]

  • 27. Steroid and calcineurin inhibitor-sparing protocols in kidney transplantation.
    Helal I, Chan L.
    Transplant Proc; 2011 Mar; 43(2):472-7. PubMed ID: 21440737
    [Abstract] [Full Text] [Related]

  • 28. Affects of immunosuppression on circulating dendritic cells: an adjunct to therapeutic drug monitoring after heart transplantation.
    Barten MJ, Garbade J, Bittner HB, Fiedler M, Dhein S, Thiery J, Mohr FW, Gummert JF.
    Int Immunopharmacol; 2006 Dec 20; 6(13-14):2011-7. PubMed ID: 17161355
    [Abstract] [Full Text] [Related]

  • 29. Conversion of long-term kidney transplant recipients from calcineurin inhibitor therapy to everolimus: a randomized, multicenter, 24-month study.
    Holdaas H, Rostaing L, Serón D, Cole E, Chapman J, Fellstrøm B, Strom EH, Jardine A, Midtvedt K, Machein U, Ulbricht B, Karpov A, O'Connell PJ, ASCERTAIN Investigators.
    Transplantation; 2011 Aug 27; 92(4):410-8. PubMed ID: 21697773
    [Abstract] [Full Text] [Related]

  • 30. Rapamycin rescue therapy in patients after kidney transplantation: first clinical experience.
    Weber T, Abendroth D, Schelzig H.
    Transpl Int; 2005 Feb 27; 18(2):151-6. PubMed ID: 15691266
    [Abstract] [Full Text] [Related]

  • 31. Regulatory T cells in renal transplantation and modulation by immunosuppression.
    López-Hoyos M, Segundo DS, Fernández-Fresnedo G, Marín MJ, González-Martín V, Arias M.
    Transplantation; 2009 Aug 15; 88(3 Suppl):S31-9. PubMed ID: 19667959
    [Abstract] [Full Text] [Related]

  • 32. Generation of donor-specific regulatory T-cell function in kidney transplant patients.
    Hendrikx TK, van Gurp EA, Sewgobind VD, Mol WM, Schoordijk W, Klepper M, Velthuis JH, Geel A, Ijzermans JN, Weimar W, Baan CC.
    Transplantation; 2009 Feb 15; 87(3):376-83. PubMed ID: 19202442
    [Abstract] [Full Text] [Related]

  • 33. Rapamycin promotes the expansion of CD4(+) Foxp3(+) regulatory T cells after liver transplantation.
    Lu L, Qian XF, Rao JH, Wang XH, Zheng SG, Zhang F.
    Transplant Proc; 2010 Jun 15; 42(5):1755-7. PubMed ID: 20620516
    [Abstract] [Full Text] [Related]

  • 34. Short-term anti-CD25 monoclonal antibody treatment and neogenetic CD4(+)CD25(high) regulatory T cells in kidney transplantation.
    Wang Z, Xiao L, Shi BY, Qian YY, Bai HW, Chang JY, Cai M.
    Transpl Immunol; 2008 Apr 15; 19(1):69-73. PubMed ID: 18346640
    [Abstract] [Full Text] [Related]

  • 35. Excellent long-term results in de novo renal transplant recipients treated with proliferation signal inhibitors and reduced calcineurin inhibitors exposure.
    Carmellini M, Collini A, Ruggieri G, Garosi G, Bernini M.
    Transplant Proc; 2008 Apr 15; 40(6):1858-61. PubMed ID: 18675070
    [Abstract] [Full Text] [Related]

  • 36. Calcineurin inhibitor-free immunosuppression in kidney transplantation.
    Guerra G, Srinivas TR, Meier-Kriesche HU.
    Transpl Int; 2007 Oct 15; 20(10):813-27. PubMed ID: 17645419
    [Abstract] [Full Text] [Related]

  • 37. Conversion to sirolimus with calcineurin inhibitor elimination vs. dose minimization and renal outcome in heart and lung transplant recipients.
    Demirjian S, Stephany B, Abu Romeh IS, Boumitri M, Yamani MH, Poggio ED.
    Clin Transplant; 2009 Oct 15; 23(3):351-60. PubMed ID: 19208105
    [Abstract] [Full Text] [Related]

  • 38. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S, He X, Yang L, Ma Y, Zhu X, Ju W, Huang J.
    Exp Clin Transplant; 2008 Jun 15; 6(2):113-7. PubMed ID: 18816237
    [Abstract] [Full Text] [Related]

  • 39. FoxP3 in peripheral blood is associated with operational tolerance in liver transplant patients during immunosuppression withdrawal.
    Pons JA, Revilla-Nuin B, Baroja-Mazo A, Ramírez P, Martínez-Alarcón L, Sánchez-Bueno F, Robles R, Rios A, Aparicio P, Parrilla P.
    Transplantation; 2008 Nov 27; 86(10):1370-8. PubMed ID: 19034005
    [Abstract] [Full Text] [Related]

  • 40. Absolute of CD4(+)CD25(+)FOXP3(+) regulatory T-cell count rather than its ratio in peripheral blood is related to long-term survival of renal allografts.
    Liu L, Deng S, Teng L, Fu Q, Wang C, He X.
    Transplant Proc; 2012 Jan 27; 44(1):284-6. PubMed ID: 22310634
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.